Antibody Test Sarscov2

Human IgG Quick test strip

E411A02-10 10 tests
EUR 150

Human IgG antibody Laboratories manufactures the antibody test sarscov2 reagents distributed by Genprice. The Antibody Test Sarscov2 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Antibody products are available in stock. Specificity: Antibody Category: Test Group: Sarscov2

Mouse IgG Quick test strip

10 tests
EUR 150

True Blue

5.0mg
EUR 595

True Blue

10mg Ask for price
Description: True Blue

True Blue

1g Ask for price
Description: True Blue

True Blue

1mg Ask for price
Description: True Blue

True Blue

50mg Ask for price
Description: True Blue

True Blue

5mg Ask for price
Description: True Blue

Sarscov2 information

SARS-CoV-2 Spike Antibody

10-2869 1 mg
EUR 1000
Description: SARS-CoV-2 Spike Antibody, Recombinant Human

SARS-CoV-2 Spike Antibody

10-2870 1 mg
EUR 1000
Description: SARS-CoV-2 Spike Antibody, Recombinant Human

SARS-CoV-2 Spike Antibody

10-2871 1 mg
EUR 1000
Description: SARS-CoV-2 Spike Antibody, Recombinant Human

SARS-CoV-2 Spike Antibody

10-2906 1 mg
EUR 225
Description: Anti-SARS-CoV-2 Spike Protein Monoclonal antibody

SARS-CoV-2 Spike Antibody

10-2907 1 mg
EUR 225
Description: Anti-SARS-CoV-2 Spike Protein Monoclonal antibody

SARS-CoV-2 (2019-nCoV) Spike Antibody, Rabbit MAb

BSV-COV-AB-09 50 ul Ask for price
Description: SARS-CoV-2 (2019-nCoV) Spike Antibody, Rabbit MAb (Spike (S1), Monoclonal)

SARS-CoV-2 (2019-nCoV) Spike Antibody, Rabbit MAb

BSV-COV-AB-10 100 ul Ask for price
Description: SARS-CoV-2 (2019-nCoV) Spike Antibody, Rabbit MAb (Spike (S1), Monoclonal)

SARS-CoV-2 (2019-nCoV) Spike Antibody, Rabbit MAb

21804 100ul
EUR 1039

Mouse Anti SARS-CoV-2 Spike (S2) Antibody (0018)

MAB12421-50 0.05
EUR 588.13
Description: Mouse monoclonal antibody against SARS-CoV-2 glycoprotein Spike S2.

Anti-Spike S1 Antibody (SARS-CoV-2)

100715-1 20 µg
EUR 300
Description: Recombinant human monoclonal antibody recognizing the SARS-CoV-2 Spike RBD glycoprotein. This antibody cross-reacts with the Spike protein from the SARS-CoV virus.

Anti-Spike S1 Antibody (SARS-CoV-2)

100715-2 100 µg
EUR 440
Description: Recombinant human monoclonal antibody recognizing the SARS-CoV-2 Spike RBD glycoprotein. This antibody cross-reacts with the Spike protein from the SARS-CoV virus.

SARS-CoV-2 Spike RBD Antibody Pair 1

55R-2273 1 set
EUR 833
Description: SARS-CoV-2 Spike RBD Antibody Pair 1

SARS-CoV-2 (COVID-19) NSP7 Antibody

9155-002mg 0.02 mg
EUR 229.7
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers.

SARS-CoV-2 (COVID-19) NSP7 Antibody

9155-01mg 0.1 mg
EUR 594.26
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers.

SARS-CoV-2 (COVID-19) NSP8 Antibody

9159-002mg 0.02 mg
EUR 229.7
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP8 plays a role in viral RNA synthesis (3,4,5). Forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers (6).

SARS-CoV-2 (COVID-19) NSP8 Antibody

9159-01mg 0.1 mg
EUR 594.26
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP8 plays a role in viral RNA synthesis (3,4,5). Forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers (6).

SARS-CoV-2 (COVID-19) NSP9 Antibody

9161-002mg 0.02 mg
EUR 229.7
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP9 may participate in viral replication by acting as a ssRNA-binding protein (3).